Wegovy day by day: what actually happens after your first dose

Wegovy is a once-weekly subcutaneous injection; each dose stays active in your body for approximately seven days, so the timeline repeats in weekly cycles.
The most common side effects are gastrointestinal (nausea, loose stools, constipation, burping) and they tend to be most noticeable in the 24–72 hours after each injection, particularly after a dose increase.
Appetite changes are real but uneven early on: some people notice reduced hunger from day three or four; others don't feel a clear shift until several weeks in.
The titration schedule (starting at 0.25 mg, rising in roughly monthly steps to 2.4 mg) exists specifically to let your body adjust, the starter doses are not expected to produce large weight changes on their own.

The first question most people have after starting Wegovy isn't about clinical trials — it's about tomorrow. Specifically: what will day two feel like, and is that nausea normal? Wegovy (semaglutide) works by activating GLP-1 receptors involved in appetite regulation and gastric emptying, and how that lands day by day varies considerably from person to person. These are prescription-only medicines; a prescriber decides whether they're right for you and guides your dose over time. What follows is an honest, fact-based picture of how the first weeks tend to unfold — drawn from the NHS and the clinical evidence.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The week-by-week reality of Wegovy: what the timeline looks like in practice

Days 1–3: the injection is done, now what?

Picture this: your pen arrives in a plain, unbranded box with DPD tracking, you put it in the fridge door, and the following morning you do your first injection. The next 72 hours are often the most unpredictable of the whole treatment.

Most people feel fine on day one. The semaglutide is entering your system gradually; the peak plasma concentration for a subcutaneous dose comes days later, not hours. By day two some people start to notice a low-grade nausea, not dramatic, but there. Fatigue is common too, along with a mild headache in some cases. Others feel nothing out of the ordinary at all.

The NHS notes that nausea, vomiting, diarrhoea and constipation are the most frequently reported side effects with semaglutide, and they tend to cluster in the early days after an injection or a dose step. The NHS semaglutide medicines page has a full side-effect breakdown worth reading before you start. If you find the first couple of days manageable, the news is usually good: most people find these early effects settle within one to two weeks at a given dose. Eating smaller portions, staying well-hydrated, and avoiding high-fat or very rich food in the first day or two after injecting tends to help.

What you almost certainly won't feel yet is a meaningful shift in appetite. That takes longer, be patient with it at this stage.

Days 4–7: the middle of the week, and the first signs of appetite change

For many people, somewhere between day three and day five is when hunger starts to feel different. Not absent, but quieter. You reach for a snack and realise you're not actually hungry. You stop halfway through a meal without forcing it. This is the GLP-1 mechanism doing what it's designed to do: slowing gastric emptying and adjusting the hormonal signals that normally drive appetite.

The gastrointestinal symptoms, if you had them, often ease off around now. That said, constipation can linger longer than nausea, fibre and fluid intake matter more during treatment than most people expect.

By day six or seven you're approaching the next injection. Some people notice that hunger edges back slightly in the final day before their next dose; this is normal at the lower starting doses and usually lessens as the dose increases over subsequent months. The full clinical picture of how semaglutide works across the titration schedule explains why the early weeks feel different from month three or four.

If you're curious about how day one specifically tends to compare with day four in terms of side-effect timing, our Wegovy day one guide covers the first 24 hours in detail, and the day four page picks up from there.

Weeks 2–4: the pattern starts to settle

After the first injection, each subsequent week tends to be somewhat easier than the last at the same dose. The second injection often brings milder nausea than the first because your body has started to adjust to the medicine's presence. By the third and fourth week, many people describe the GI side effects as background noise rather than a disruption.

The appetite suppression, by contrast, often deepens. Portion sizes shrink without much conscious effort. The desire to graze between meals fades. This is also the window where the behavioural shift that supports the clinical results begins to take root, not just eating less, but starting to notice a different relationship with food.

The STEP 1 trial, published in the New England Journal of Medicine, followed people taking 2.4 mg semaglutide over 68 weeks and recorded an average body-weight reduction of around 15%. That figure is a population average across the full treatment course. What happens in week three is part of a much longer arc; it's not where the meaningful numbers land. Understanding the cost of Wegovy over that full course is worth doing at this stage too, before committing to the longer titration.

If your dose increases at the four-week mark (which your prescriber will decide based on how you've tolerated the starter dose) the early-days side-effect pattern can reset slightly. Think of a dose increase as a mini week one: the same caution with food, the same patience for a few days.

What to watch for, and when to act

Most of what people experience day by day with Wegovy is uncomfortable rather than dangerous. The side effects described above are expected and documented. There are a handful of things that warrant prompt medical attention, though, and it's worth knowing them before you start.

Severe, persistent stomach pain (particularly if it radiates toward your back and comes with vomiting) should be assessed urgently. The MHRA highlighted acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines in a Drug Safety Update published in January 2026; this is the symptom profile to watch for. Gallbladder symptoms (sharp pain under the right ribs) are also worth flagging to your GP rather than waiting. If GI side effects are so severe that you can't keep fluids down, dehydration becomes a real concern, call your prescriber or 111.

Signs of an allergic reaction (swelling, difficulty breathing, widespread rash) require emergency care. And if you notice low mood or any thoughts of self-harm, tell your prescriber promptly, these are listed in the product information as things to monitor.

For anything short of the above, your prescriber and our aftercare team at nume support are there seven days a week. The day-by-day experience is something our clinical team, including our lead prescriber, see questions about regularly, there's rarely a concern that hasn't come up before. If you're still weighing up whether Wegovy is right for you, a free consultation with our prescribers is the logical next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions